Skip to main content
Atrás
Watch Compare

Autonomix Medical, Inc.

Calidad de datos: 100%
AMIX
NASDAQ Manufacturing Measuring & Analyzing Instruments
$0.38
▼ $0.01 (-2.21%)
Cap. Mercado: 4.56 M
6 months return
—
Momentum
Neutral
ROE
-229.77%

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Negative free cash flow of -11.95 M

Price History

Crecimiento

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
-229.77%
Below sector avg (-54.49%)
ROIC-184.78%
Net MarginN/A
Op. MarginN/A

Seguridad

Debt / Equity
N/A
Current Ratio6.18
Interest Coverage-230.91

Valoración

PE (TTM)
-0.26
Above sector avg (-1.50)
P/B Ratio0.53
EV/EBITDAN/A
Dividend YieldN/A

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (1605 pares)
Métrica Acción Mediana del Sector
P/E -0.3 -1.5
P/B 0.5 1.6
ROE % -229.8 -54.5
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

Precio Objetivo de Analistas

1 analista

Consenso de analistas: objetivo medio vs precio actual y calificación.

Strong Buy
Actual
$0.38
+431.8%
Objetivo
$2.00
$2.00
$2.00
$2.00
Pronóstico
EPS Futuro -$1.63
Ingresos Est. 0.0

Estimaciones de Ganancias

Pronósticos de EPS e ingresos por período. Anual = años fiscales; trimestral = próximos trimestres.

Período EPS Est. Ingresos Est. Analistas
FY2027 -$1.63
-$2.34 – -$0.91
0.0 2
FY2026 -$2.35
-$2.35 – -$2.35
0.0 1

Sorpresas de Ganancias

Últimos 4 trimestres
Trimestre EPS Est. EPS Real Sorpresa
Q42025 -$0.46 -$0.36 +21.7%
Q32025 -$1.50 -$1.38 +8.0%
Q22025 -$0.98 -$1.07 -9.2%
Q12025 -$1.24 -$0.74 +40.1%

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0.0 Net Income (TTM) -17.24 M
ROE -229.77% ROA -190.05%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -11.95 M
ROIC -184.78% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 6.18
Interest Coverage -230.91 Asset Turnover 0.00
Working Capital 8.54 M Tangible Book Value 8.56 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.26 Forward P/E N/A
P/B Ratio 0.53 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -261.96%
Market Cap 4.56 M Enterprise Value -5.37 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share 0.00
FCF / Share -1.05 OCF / Share -1.05
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 69.33%
SBC-Adj. FCF -13.70 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024
Revenue 0.0 0.0
Net Income -11.41 M -15.43 M
EPS (Diluted) — —
Gross Profit — —
Operating Income -11.59 M -12.03 M
EBITDA — —
R&D Expenses 4.73 M 2.23 M
SG&A Expenses — —
D&A 183,000.0 81,000.0
Interest Expense 176,000.0 79,000.0
Income Tax 0.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024
Total Assets 9.81 M 9.41 M
Total Liabilities 1.71 M 1.78 M
Shareholders' Equity 8.10 M 7.63 M
Total Debt — —
Cash & Equivalents 9.14 M 8.61 M
Current Assets 9.61 M 9.39 M
Current Liabilities 1.71 M 777,000.0